IP Library Granted Patent US 10,791,982
Granted Patent B2
US 10,791,982 · App. 15/306,811 · Granted Oct 6, 2020

Methods of measuring head, neck, and brain function and predicting and diagnosing memory impairment

Inventor: Stephanie Littell (Lexington, MA)
A61B5/4088A61B5/021A61B5/0261A61B5/031A61B5/032A61B5/1455A61B5/14546A61B5/14553A61B5/168A61B5/6814A61B5/6898A61B5/7271A61B5/742A61B5/746
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,791,982
App. No.
15/306,811
Granted
Oct 6, 2020
Kind
B2
Abstract

A computer based method and system forms measurements of brain function and predictions of a likelihood for memory impairment via the use of cameras, including a near-infrared (NIR) spectroscopic device and a camera capturing images in the Red-Green-Blue (RGB) spectrum. The device acquires from a subject measurements of ions, molecules, or combinations thereof at more than one moment in time, as well as amplitude and timing of blood pulsations. Based on the measured molecule or ion concentration, flow, and so forth, a processor assesses the probability of a neuron to form an action potential. Formation of an action potential increases the probability that the subject individual will create a memory.

Claims (33)

1. A method for predicting a likelihood for memory impairment in an individual, the method comprising:

a) using a near infrared spectroscopic device on an individual at an anatomical region to be studied;

b) determining, with the device at the anatomical region, a first measurement of at least one of an oxygen concentration (PaO 2 ), an oxygen saturation (O 2 sat), a hemoglobin (Hb) concentration, a carbon dioxide (CO 2 ) concentration, a carbonic acid (H 2 CO 3 ) concentration, and a hydrogen ion (H + ) concentration at a first time;

c) determining, with the device at the anatomical region, a second measurement of the at least one of the oxygen concentration (PaO 2 ), the oxygen saturation (O 2 sat), the hemoglobin (Hb) concentration, the carbon dioxide (CO 2 ) concentration, the carbonic acid (H 2 CO 3 ) concentration, and the hydrogen ion (H + ) concentration at a second time;

d) comparing the first measurement to the second measurement; and

e) determining, based on step (d), a probability for one or more neurons to generate an action potential, wherein the generation of an action potential increases the probability of forming a new memory;

thereby predicting the likelihood for memory impairment in the individual.

2. The method of claim 1 , wherein the first time is a first moment or a first time interval and the second time is a second moment or a second time interval.

3. The method of claim 1 , further comprising establishing a baseline from one or more measurements of the at least one of the oxygen concentration (PaO 2 ), the oxygen saturation (O 2 sat), the hemoglobin (Hb) concentration, the carbon dioxide (CO 2 ) concentration, the carbonic acid (H 2 CO 3 ) concentration, and the hydrogen ion (H + ) concentration at the first time, wherein the baseline represents a memory map of the individual.

4. The method of claim 3 , further comprising normalizing the memory map based on the individual's age, gender, or other characteristic.

5. The method of claim 1 , further comprising assessing hypoxia, acidosis, or a combination thereof, based on steps (a)-(c), wherein a presence of hypoxia, acidosis, or combination thereof relates to an increased likelihood of memory impairment.

6. The method of claim 5 , wherein the first and second measurements include at least one of oxygen concentration (PaO 2 ), oxygen saturation (O 2 sat), hemoglobin (Hb) concentration, and carbon dioxide (CO 2 ) concentration, and the presence of hypoxia is determined based on the first and second measurements.

7. The method of claim 5 , wherein the first and second measurements include at least one of carbonic acid (H 2 CO 3 ) concentration and hydrogen ion (H + ) concentration, and the presence of acidosis is determined based on the first and second measurements.

8. The method of claim 1 , further comprising measuring cerebral blood pressure, cerebral blood flow, cerebrospinal fluid pressure, cerebrospinal fluid flow, intracranial pressure, or combinations thereof.

9. The method of claim 1 , wherein the region comprises a forehead of the individual.

10. The method of claim 1 , wherein the region comprises a frontal, parietal, occipital, limbic, or temporal lobe of the individual.

11. The method of claim 1 , wherein the device is a portable device, such as a cell phone, tablet, laptop computer, or wearable aid.

12. The method of claim 1 , wherein the device comprises a camera and software for measuring the one or more ions, one or more molecules, or combinations thereof.

13. A computer system to predict a likelihood for memory impairment in an individual, the system comprising:

a measuring module configured to determine a first measurement of at least one of an oxygen concentration (PaO 2 ), an oxygen saturation (O 2 sat), a hemoglobin (Hb) concentration, a carbon dioxide (CO 2 ) concentration, the carbonic acid (H 2 CO 3 ) concentration, and the hydrogen ion (H + ) concentration at a first time; and configured to determine a second measurement of the at least one of the oxygen concentration (PaO 2 ), the oxygen saturation (O 2 sat), the hemoglobin (Hb) concentration, the carbon dioxide (CO 2 ) concentration, the carbonic acid (H 2 CO 3 ) concentration, and the hydrogen ion (H + ) concentration at a second time;

a comparison module configured to receive and compare the first measurement to the second measurement; and

a probability module coupled to the comparison module and configured to determine a probability for one or more neurons to generate an action potential, wherein the generation of an action potential increases the probability of forming a new memory;

from the determined probability, the probability module forming a prediction of the likelihood for memory impairment in the individual.

14. The computer system of claim 13 , wherein the first time is a first moment or a first time interval and the second time is a second moment or a second time interval.

15. The computer system of claim 13 , further comprising a baseline module responsive to the measuring module and configured to establish a baseline from one or more measurements of the at least one of the oxygen concentration (PaO 2 ), the oxygen saturation (O 2 sat), the hemoglobin (Hb) concentration, the carbon dioxide (CO 2 ) concentration, the carbonic acid (H 2 CO 3 ) concentration, and the hydrogen ion (H + ) concentration at the first time, wherein the baseline represents a memory map of the individual.

16. The computer system of claim 15 , further comprising a normalization module configured to normalize the memory map based on the individual's age, sex, or other characteristic.

17. The computer system of claim 13 , further comprising an assessment module responsive to the measuring module and configured to assess hypoxia, acidosis, or a combination thereof, wherein a presence of hypoxia, acidosis, or combination thereof relates to an increased likelihood for memory impairment.

18. The computer system of claim 17 , wherein the first and second measurements include at least one of oxygen concentration (PaO 2 ), oxygen saturation (O 2 sat), hemoglobin (Hb) concentration, and carbon dioxide (CO 2 ) concentration, and the presence of hypoxia is determined based on the first and second measurements.

19. The computer system of claim 17 , wherein the first and second measurements include at least one of carbonic acid (H 2 CO 3 ) concentration and hydrogen ion (H + ) concentration, and the presence of acidosis is determined based on the first and second measurements.

20. The computer system of claim 13 , further comprising a second measuring module configured to measure cerebral blood pressure, cerebral blood flow, cerebrospinal fluid pressure, cerebrospinal fluid flow, intracranial pressure, or combinations thereof.

21. The computer system of claim 13 , further comprising a device module configured to connect one or more infrared spectroscopic devices operatively coupled to the measuring module.

22. The computer system of claim 21 , wherein the infrared spectroscopic device is a portable device, such as a cell phone, tablet, laptop computer, or wearable aid.

23. The computer system of claim 21 , wherein the infrared spectroscopic device comprises a camera and is configured to measure the one or more ions, one or more molecules, or combinations thereof.

Continuity (3)
Provisional Application 62092580 · Dec 16, 2014
Provisional Application 61987626 · May 2, 2014
Related Publication 20170049377A1 · Feb 23, 2017